I.F. FAYRUSHINA^{1, 2}

 ¹Kazan State Medical University, Kazan

2Republic Clinical Hospital, Kazan

  Contact details:

Fayrushina I.F. — PhD (medicine), Assistant Lecturer of the Department of Hospital Therapy

Address: 49 Butlerov St., Kazan, Russian Federation, 420012, tel.: +7-987-186-26-56, e-mail: sirenif@mail.ru

Nailfold capillaroscopy (NFC) is a non-invasive and safe tool for microvasculature assessment. Since its recent inclusion to classification criteria for systemic sclerosis (American College of Rheumatology (ACR) / European League Against Rheumatism (EULAR), 2013) and monitoring disease progression, the importance of NFC in rheumatology has increased. Given its growing use by a variety of physicians worldwide, both in daily practice to differentiate primary and secondary Raynaud’s syndrome, and in the context of research to predict the progression of the disease and evaluate the treatment effectiveness, the description of the acquisition and analysis of capillaroscopic images remains relevant. This report provides information on the interpretation of NFC changes, particularly in systemic sclerosis and other rheumatic diseases.

Key words: nailfold capillaroscopy, systemic sclerosis, rheumatic diseases, scleroderma pattern.

REFERENCES

1. Chojnowski M.M., Felis-Giemza A., Olesińska M. Capillaroscopy — a role in modern rheumatology. Reumatologia, 2016, vol. 54 (2), rr. 67–72.
2. Raynaud M. De l’asphyxie locale et de la gangrènesymétrique des extrémités. Paris: Leclerc, 1862.
3. Smith V., Herrick A.L., Ingegnoli F. et al. Standardisation of nailfold capillaroscopy for the assessment of patients with Raynaud’s phenomenon and systemic sclerosis. Autoimmunity Reviews, 2020, r. 102458.
4. Bernardino V. et al. The Impact of Nailfold Capillaroscopy in the Approach of Microcirculation. Vascular Biology — Selection of Mechanisms and Clinical Applications. – 2019.
5. Ingegnoli F., Ardoino I, Boracchi P. Nailfold capillaroscopy in systemic sclerosis: Data from the EULAR scleroderma trials and research (EUSTAR) database. Microvascular Research, 2013, vol. 89, rr. 122–128.
6. Van den Hoogen F., Khanna D., Fransen J. et al. 2013 classification criteria for systemic sclerosis: an American College of Rheumatology / European League against Rheumatism collaborative initiative. Arthritis and rheumatism, 2013, vol. 65 (11), rr. 2737–2747.
7. Cutolo M., Zampogna G., Vremis L. et al. Longterm effects of endothelin receptor antagonism on microvascular damage evaluated by nailfold capillaroscopic analysis in systemic sclerosis. The Journal of Rheumatology, 2013, vol. 40, rr. 40–45.
8. Cutolo M., Ruaro B., Pizzorni C. et al. Longterm treatment with endothelin receptor antagonist bosentan and iloprost improves fingertip blood perfusion in systemic sclerosis. The Journal of Rheumatology, 2014, vol. 41, rr. 881–886.
9. Trombetta A.C., Pizzorni C., Ruaro B. et al. Effects of longterm treatment with bosentan and iloprost on nailfold absolute capillary number, fingertip blood perfusion, and clinical status in systemic sclerosis. The Journal of Rheumatology, 2016, vol. 43, rr. 2033–2041.
10. Sebastiani M., Manfredi A., Lo Monaco A. et al. Capillaroscopic Skin Ulcers Risk Index (CSURI) calculated with different videocapillaroscopy devices: how its predictive values change. Clin Exp Rheumatol, 2013, vol. 31 (2), rr. 115–117.
11. Sebastiani M., Manfredi A., Vukatana G. et al. Predictive role of capillaroscopic skin ulcer risk index in systemic sclerosis: a multicentre validation study. Ann Rheum Dis, 2012, vol. 71 (1), rr. 67–70.
12. Karbalaie A., Emrani Z., Fatemi A. et al. Practical issues in assessing nailfold capillaroscopic images: A summary. Clinical Rheumatology, 2019, vol. 38, rr. 2343– 2354.
13. Soulaidopoulos S., Triantafyllidou E., Garyfallos A. et al. The role of Nailfold capillaroscopy in the assessment of internal organ involvement in systemic sclerosis: A critical review. Autoimmunity Reviews, 2017, vol. 16, rr. 787–795.
14. Lisco G., Cicco G., Cignarelli A. et al. Computerized video-capillaroscopy alterations related to diabetes mellitus and its complications. Advances in Experimental Medicine and Biology, 2018, vol. 1072, rr. 363–368.
15. Emrani Z., Karbalaie A., Fatemi A. et al. Capillary density: An important parameter in nailfold capillaroscopy. Microvascular Research, 2017, vol. 109, rr. 7–18.
16. Gurfinkel Y., Sasonko M.L., Priezzhev A.V. Digital capillaroscopy as important tool for early diagnostics of arterial hypertension. Proceedings of SPIE, 2015, vol. 9448, rr. 944804.
17. Shirshin E.A., Gurfinkel Y.I., Matskeplishvili S.T. et al. In vivo optical imaging of the viable epidermis around the nailfold capillaries for the assessment of heart failure severity in humans. Journal of Biophotonics, 2018, vol. 11 (9). e201800066.
18. Ghizzoni C., Sebastiani M., Manfredi A. et al. Prevalence and evolution of scleroderma pattern in nailfold videocapillaroscopy in systemic sclerosis patients: Clinical and prognostic implications. Microvascular Research, 2015, vol. 99, rr. 92–95.
19. Tavakol M.E., Fatemi A., Karbalaie A. et al. Nailfold Capillaroscopy in rheumatic diseases: Which parameters should be evaluated? Journal of Biomedicine and Biotechnology, 2015, r. 974530.
20. Cutolo M., Melsens K., Wijnant S. et al. Nailfold capillaroscopy in systemic lupus erythematosus: A systematic review and critical appraisal. Autoimmunity Reviews, 2018, vol. 17, rr. 344–352.
21. Murdaca G., Colombo B.M., Cagnati P. et al. Endothelial dysfunction in rheumatic autoimmune diseases. Atherosclerosis, 2012, vol. 224, rr. 309–317.
22. Cutolo M. Atlas of Capillaroscopy in Rheumatic Diseases. Milano: Elsevier, 2012.
23. Manfredi A., Sebastiani M., Cassone G. et al. Nailfold Capillaroscopi changes in dermatomyositis and polymyositis. Clinical Rheumatology, 2015, vol. 34, rr. 279–284.
24. Selva-O’Callaghan A., Fonollosa-Pla V., TRallero-Araguás E. et al. Nailfold capillary microscopy in adults with inflammatory myopathy. Seminars in Arthritis and Rheumatism, 2010, vol. 39 (5), rr. 398–404.
25. Jammal M., Kettaneh A., Cabane J. et al. Capillaroscopiepériunguéale: uneévaluation simple et fiable de toutepathologie de la microcirculation. La Revue de Médecine Interne, 2015, vol. 36, rr. 603–612.
26. De Holanda A., Bonfá E., Fuller R., et al. Capillaroscopy is a dynamic process in mixed connective tissue disease. Lupus, 2007, vol. 16, rr. 254–258.
27. Elmotaleb G., Yasser A., Hamoud H.S., Sherif Mohamedl. et.al. Nailfold Capillaroscopy in Early Stages of Mixed Connective Tissue Disease in a Sample of Egyptian Patients. Indian Journal of Rheumatology, 2023, vol. 18 (1), rr. 61–67.
28. Rajaei A., Dehghan P., Amiri A. Nailfold capillaroscopy in 430 patients with rheumatoid arthritis. Caspian J Intern Med, 2017, vol. 8 (4), rr. 269–274.
29. Ribeiro C., Holler A., Skaer T. et al. Periungual capillaroscopy in psoriasis. Anais Brasileiros de Dermatologia, 2012, vol. 87 (4), rr. 550–553.
30. Sivasankari M., Arora S., Vasdev V., Mary E.M. Nailfold capillaroscopy in psoriasis. Med J Armed Forces India, 2021, vol. 77 (1), rr. 75–81.